Yangzhou Wang is the founder of Porton Advanced Solutions. Porton Advanced Solutions has raised $80M in total funding. Latest round: Series B.
Yangzhou Wang is the CEO of Porton Advanced Solutions, a company focused solely on gene and cell therapy CDMO (Contract Development and Manufacturing Organization) services. Porton Advanced has established an integrated CDMO platform offering various services including plasmids, cell therapy, gene therapy, oncolytic virus, nucleic acid therapy, and microbial vectors for gene therapy. The company recently completed a Series B financing round raising over US$80 million.
Full founder directory · Investor directory · Company funding database · Fundraising library